Literature DB >> 18152341

The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III.

W B WOOD, M R SMITH.   

Abstract

Five strains of type III pneumococcus have been shown to possess wide capsular slime layers during the logarithmic phase of growth in serum broth. The slime layer stains metachromatically with methylene blue and can be visualized under the electron microscope as a fuzzy halo which extends well beyond the surace of the capsule proper and causes centrifugates of the organism to be of extremely large volume. This outer capsular structure is most readily demonstrated in vivo and in nutrient broth containing glucose and serum. It disappears from the surface of the cell with aging of the culture, and is easily removed by dilute alkali, alcohol, and heat. Exposure of slime-covered type III pneumococci to homologous antibody and to type III polysaccharidase reveals that the slime layer contains the same type-specific polysaccharide that is present in the rest of the capsule. From a type III strain producing a prominent slime layer an intermediate mutant has been isolated which forms small non-mucoid colonies on blood agar and possesses a relatively small capsule with a barely discernible slime layer. The wide slime layer protects virulent type III pneumococci from surface phagocytosis. Whenever the type III cells lose their broad slime layer, whether from aging of the culture, from mutation, from exposure to injurious chemicals, or from the action of type III polysaccharidase, they become susceptible to phagocytosis by the surface mechanism. Once phagocyted the type III pneumococci are promptly destroyed, even in the absence of antibodies.

Entities:  

Keywords:  PHAGOCYTES AND PHAGOCYTOSIS; PNEUMOCOCCI

Mesh:

Substances:

Year:  1949        PMID: 18152341      PMCID: PMC2135934          DOI: 10.1084/jem.90.1.85

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Bacterial Morphology as Shown by the Electron Microscope: VI. Capsule, Cell-Wall and Inner Protoplasm of Pneumococcus, Type III.

Authors:  S Mudd; F Heinmets; T F Anderson
Journal:  J Bacteriol       Date:  1943-08       Impact factor: 3.490

2.  Pneumococcus Variants: I. Intermediate Forms and the Influence of Environment in Their Production During In-vitro S to R and R to S Transitions.

Authors:  J R Paul
Journal:  J Bacteriol       Date:  1934-07       Impact factor: 3.490

3.  Pneumococcus Variants Intermediate between the S and R Forms.

Authors:  F G Blake; J D Trask
Journal:  J Bacteriol       Date:  1933-03       Impact factor: 3.490

4.  Intercellular Surface Phagocytosis.

Authors:  W B Wood; M R Smith
Journal:  Science       Date:  1947-07-25       Impact factor: 47.728

5.  STEPWISE INTRATYPE TRANSFORMATION OF PNEUMOCOCCUS FROM R TO S BY WAY OF A VARIANT INTERMEDIATE IN CAPSULAR POLYSACCHARIDE PRODUCTION.

Authors:  C M Macleod; M R Krauss
Journal:  J Exp Med       Date:  1947-11-30       Impact factor: 14.307

6.  THE INTERCONVERTIBILITY OF "R" AND "S" FORMS OF PNEUMOCOCCUS.

Authors:  M H Dawson
Journal:  J Exp Med       Date:  1928-03-31       Impact factor: 14.307

7.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG.

Authors:  M R Smith; W B Wood
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

8.  THE SPECIFIC POLYSACCHARIDES OF TYPES I, II, AND III PNEUMOCOCCUS : A REVISION OF METHODS AND DATA.

Authors:  M Heidelberger; F E Kendall; H W Scherp
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

9.  STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : III. CORRELATION OF THE BEHAVIOR IN VIVO OF PNEUMOCOCCI TYPE III VARYING IN THEIR VIRULENCE FOR RABBITS WITH CERTAIN DIFFERENCES OBSERVED IN VITRO.

Authors:  J F Enders; M F Shaffer; C J Wu
Journal:  J Exp Med       Date:  1936-07-31       Impact factor: 14.307

10.  STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : II. CERTAIN DISTINGUISHING PROPERTIES OF TWO STRAINS OF PNEUMOCOCCUS TYPE III VARYING IN THEIR VIRULENCE FOR RABBITS, AND THE REAPPEARANCE OF THESE PROPERTIES FOLLOWING R-->S RECONVERSION OF THEIR RESPECTIVE ROUGH DERIVATIVES.

Authors:  M F Shaffer; J F Enders; C J Wu
Journal:  J Exp Med       Date:  1936-07-31       Impact factor: 14.307

View more
  28 in total

1.  [Not Available].

Authors:  W MASSHOFF; W ADAM
Journal:  Arch Klin Exp Dermatol       Date:  1957

2.  Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability.

Authors:  K Aaron Geno; Jocelyn R Hauser; Kanupriya Gupta; Janet Yother
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

3.  Action of capsular polysaccharide and a polygalacturonate on the development and the virulence of Pneumococcus type III.

Authors:  A NOVELLI
Journal:  Experientia       Date:  1952-05-15

4.  Initiation and synthesis of the Streptococcus pneumoniae type 3 capsule on a phosphatidylglycerol membrane anchor.

Authors:  Robert T Cartee; W Thomas Forsee; Janet Yother
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.

Authors:  M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

6.  An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery.

Authors:  M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

7.  Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E.

Authors:  David B A James; Kanupriya Gupta; Jocelyn R Hauser; Janet Yother
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

8.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

9.  Genetic and biochemical characterizations of enzymes involved in Streptococcus pneumoniae serotype 2 capsule synthesis demonstrate that Cps2T (WchF) catalyzes the committed step by addition of β1-4 rhamnose, the second sugar residue in the repeat unit.

Authors:  David B A James; Janet Yother
Journal:  J Bacteriol       Date:  2012-09-21       Impact factor: 3.490

10.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.